ClinicalTrials.Veeva

Menu

Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications: an Event-related Potentials Study

C

CHU Brugmann University Hospital

Status

Enrolling

Conditions

Alcohol Use Disorder

Treatments

Device: Neurofeedback active
Device: Neurofeedback placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05913518
Neurofeedback

Details and patient eligibility

About

Addressing cognitive deficits in alcohol use disorder (AUD) supports recovery. Impaired metacognitive functioning in AUD causes compromised recognition of the interoceptive state leading to the maintenance of alcohol abuse despite negative consequences. By promoting greater self-awareness and self-regulation, neurofeedback training is of high relevance in metacognition remediation to support abstinence.

The main objective of the present study is to validate neurofeedback as a complementary clinical tool to overcome metacognitive deficits that represent a significant factor in the maintenance of harmful consumption behavior and relapse phenomena in AUD.

Enrollment

130 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged between 18 and 65 years old undergoing a 3- to 4-week detoxification treatment program at the Alcohol Unit of CHU Brugmann hospital (Brussels, BELGIUM), who have been diagnosed with severe AUD (alcohol use disorder) according to the DSM-V-TR.

Exclusion criteria

  • history of neurological disorders
  • other serious medical conditions
  • neuroleptic treatment are excluded.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

130 participants in 3 patient groups, including a placebo group

Active neurofeedback group
Experimental group
Treatment:
Device: Neurofeedback active
Placebo feedback group
Placebo Comparator group
Treatment:
Device: Neurofeedback placebo
Control group
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Clémence Dousset; Salvatore Campanella

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems